Antibodies active against SARS-CoV-2 found in 20-year-old library

Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.

New Pfizer and Merck antivirals look hopeful

With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.

Study reveals what makes the Delta variant so infectious

A part of the SARS-CoV-2 spike protein could prove to be its Achilles’ heel.

Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice

A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.

Third shot of COVID-19 vaccine not justified, says research

An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.

Sign up for our newsletter

Receive the latest science news directly to your inbox once a week

Have a question or feedback?

Contact the Advanced Science News editorial team at advsciencenews@wiley.com.